🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Zihan Quan

South China Normal University

ORCID: 0009-0003-2795-1172

Also affiliated with Chengdu University of Technology, Chengdu University

MedicinePsychologyNeuroscienceBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: DNA topoisomerase II inhibition potentiates osimertinib’s therapeutic efficacy in EGFR-mutant non–small cell lung cancer models.

30 citations

Karin A. Vallega, Dongsheng Wang, Zihan Quan, Songqing Fan, Qiming Wang +4 more

10 citations

Karin A. Vallega, Vijay K. Boda, Zihan Quan, Dongsheng Wang, Songqing Fan +5 more